Systemic serous hypoperfusion

Systemic Serous Hypoperfusion (Literally : bodywide, clear fluids, insufficient flow)

A body wide malfunction in the natural flow of serous / lymphatic fluids.

Discovered in October, 2000 by Anne R. Hillebrand, Orlando, FL USA.

Serous / Lymphatic Fluid, the end-product of blood, is produced by the arterial capillaries and flows into the body tissue. In the case of Systemic Serous Hypoperfusion, it is too thick to reach the extremities and to exit body tissue via the Lymphatic Capillaries.

The Serous / Lymphatic fluids are critical. They feed, lubricate and rinse all the cells in the body and maintain and repair cartilage and vertebral discs. Once this fluid leaves the Arterial Capillaries, it is no longer pumped by the heart; it should be propelled by the contraction of muscles. Pain and many other serious symptoms occur when the movement of muscles is not sufficient to move the overly-thick fluid through the body tissue and on out through the Lymphatic Capillaries.

This body wide starvation and stagnation, Systemic Serous Hypoperfusion, is the cause of the symptoms of Fibromyalgia. It is a factor in other illnesses, including TMD, Glaucoma, OA and RA. Its role in additional illnesses is rapidly being recognized by formal researchers in a wide variety of disciplines.

These critical fluids are clear and are just too thick - not outside of their normal paths - so the malfunction had not been previously detected by MRI's, X-rays, EMG's, CT Scans, physical exams or blood tests.

Hillebrand developed the FibroFix treatment method for Fibromyalgia that restores the natural flow of these fluids bodywide.

The treatment reverses the symptoms of Fibromyalgia. It is not intended as a cure, but can lead to normal health with very minimal further treatment in some individuals; once the body returns to normal activity, muscle movement sustains the natural flow.

The intial understanding of this systemic problem lead to 40+ other discoveries about Fibromyalgia by Hillebrand.

These discoveries and all details of the treatment are provided as free, public domain, information on the www.FibroFix.com web site.